The importance of IL-6 trans-signaling was further supported by our in vitro studies of SSc fibroblasts derived from patients with limited cutaneous SSc, suggesting IL-6 as a commonly dysregulated signaling pathway in multiple scleroderma subsets. The gene discussed is IL6; the disease is systemic sclerosis.